GOSS (Gossamer Bio) 3-1 Month Momentum %: -62.96% (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GOSS Gossamer Bio Inc GOSS
16 GF Score
Price $0.16
! 5 Warning Signs
View Full Analysis

What is Gossamer Bio 3-1 Month Momentum %?

Gossamer Bio GOSS +0.12% 16 3-1 Month Momentum % is -62.96% as of Jul. 16, 2026. GuruFocus rates GOSS with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 1,382 Biotechnology companies, Gossamer Bio ranks worse than 98.05% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-16), Gossamer Bio's 3-1 Month Momentum % is -62.96%.

The industry rank for Gossamer Bio's 3-1 Month Momentum % or its related term are showing as below:

GOSS's 3-1 Month Momentum % is ranked worse than
98.05% of 1382 companies
in the Biotechnology industry
Industry Median: -12.31 vs GOSS: -62.96

Gossamer Bio  (NAS:GOSS) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Gossamer Bio 3-1 Month Momentum % Related Terms

GOSS vs ELTX, ACET, EDSA: 3-1 Month Momentum % Comparison

For the Biotechnology subindustry, Gossamer Bio's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gossamer Bio 3-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gossamer Bio's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Gossamer Bio's 3-1 Month Momentum % falls into.


GOSS
16GF Score
Gossamer Bio Inc GOSS
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gossamer Bio  (NAS:GOSS) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -62.96% mean?
Gossamer Bio (GOSS) has a 3-1 Month Momentum % of -62.96% as of Jul. 16, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Gossamer Bio and its competitors. According to the industry distribution chart, Gossamer Bio ranks #1355 out of 1382 companies in the Biotechnology industry, placing it in the top 98%.
Is Gossamer Bio's 3-1 Month Momentum % too high?
Gossamer Bio's current 3-1 Month Momentum % is -62.96%. Based on the distribution chart, Gossamer Bio ranks #1355 out of 1382 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Gossamer Bio has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Gossamer Bio's 3-1 Month Momentum % compare to ELTX and ACET?
According to the Biotechnology industry distribution chart, Gossamer Bio ranks #1355 out of 1382 companies for 3-1 Month Momentum %. This places Gossamer Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Gossamer Bio and its competitors. Gossamer Bio's current 3-1 Month Momentum % is -62.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gossamer Bio stock overvalued right now?
Gossamer Bio (GOSS) has a current 3-1 Month Momentum % of -62.96%. The current 3-1 Month Momentum % is -62.96%. Gossamer Bio's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Gossamer Bio (GOSS), the current 3-1 Month Momentum % is -62.96% as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gossamer Bio Business Description

Other Exchanges 4GB:Germany
Address 3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
16GF Score

Get the complete analysis for GOSS

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price